CVSG CVS Group plc

18.33USD1392.00 GBp · LSE-0.57%Mkt Cap: 1.22B USDP/E: 58.00

CVS Group plc, together with its subsidiaries, engages in veterinary practices, online pharmacy, veterinary diagnostic, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practi…

Institutional holders11 on file

Key Statistics

Company
Market Cap1.22B USD
Enterprise Value1.68B USD
Revenue (TTM)938.65M USD
Gross Profit415.60M USD
Net Income (TTM)23.44M USD
Revenue/Share13.25 USD
Last Price18.33 USD
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees9.0K
CountryGB
SectorHealthcare
IndustryMedical Care Facilities
ISINGB00B2863827
Valuation
P/E (Trailing)58.00
P/E (Forward)13.41
PEG—
EV/EBITDA13.81
EV/Revenue1.79
P/S1.30
P/B3.32
EPS (TTM)0.32 USD
EPS (Forward)1.37 USD
52W Range
0.000097% of range18.95
52W High18.95 USD
52W Low0.0000 USD
Profitability
Gross Margin44.28%
Oper. Margin6.96%
EBITDA Margin12.96%
Profit Margin2.50%
ROE6.14%
ROA2.32%
ROIC4.43%
ROCE7.42%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF93.89M USD
CapEx (TTM)47.93M USD
FCF Margin5.99%
FCF Yield4.61%
Net Debt397.56M USD
Net Debt/EBITDA3.27
Net Debt/FCF7.07
Balance Sheet
Debt/Equity1.10
Current Ratio1.18
Quick Ratio0.81
Book Value/Sh5.52 USD
Cash/Share0.35 USD
Dividends
Fwd Div Rate0.0012 USD
Trail. Div Rate0.0012 USD
Div. Yield0.64%
5Y Avg Yield0.50%
Payout Ratio34.98%
Ex-Div DateNov 5, 2026
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.94 USD
Upside (mean)+14.3%
Target Range16.46 USD – 26.34 USD
16.46+14.3% to mean26.34
# Analysts12
Ownership
Shares Out.66.53M
Float67.96M
Insiders0.75%
Institutions86.55%
Technical
SMA 5016.95 (+8.2%)
SMA 20016.48 (+11.2%)
Beta1.04
S&P 52W Chg12.08%
Avg Vol (30d)359.06K
Avg Vol (10d)396.18K
Technical Indicators
RSI (14)62.3
MACD33.2764
MACD Signal34.5115
MACD Hist.-1.2351
BB Upper18.96 USD
BB Middle17.99 USD
BB Lower17.03 USD
BB Width10.67%
ATR (14)0.4733 USD
Vol Ratio (20d)0.70x

About CVS Group (LON: CVSG)

›

CVS Group (LON: CVSG) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 9,000 employees.

The shares were at 1392.00 GBp on 19 November 2026, up 15.6% over 52 weeks.

At a market capitalisation of 926.03M GBP, it trades at 58.0 times trailing earnings and 13.4 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a premium of 145% for CVSG. It pays a dividend yielding 0.64% (it pays out 35% of its earnings), against a median of 0.75% among the dividend payers in that peer group.

CVS Group reports return on equity of 6.1% and an operating margin of 7.0%.

Its debt exceeds its cash by 301.90M GBP, a debt-to-equity ratio of 1.10. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 1590.42 GBp is 14.3% above the current price. The next earnings report is expected on 25 February 2027.